Roche’s Genentech inks deal with Sosei Heptares
Under the terms of the agreement, Sosei Heptares is eligible to receive US$26 million in upfront and near-term payments.
Read More
Tag: G protein-coupled receptor
- HUTCHMED begins global trial of novel attc therapy hmpl‑a580 in solid tumours
- Theolytics awarded €8 million Horizon Europe grant to fund ovarian cancer study
- AI system aims to uncover Alzheimer’s earlier and take on diagnostic delays
- Quell launches chill phase 1/2 trial for novel cartreg therapy
- Bioxytran reports positive phase 1b/2a results for antiviral ProLectin‑M
